ASMB CIK: 1426800

Assembly Biosciences Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−93.4
FY22:
−84.5
FY23:
22.7
FY24:
−51.1
FY25:
−41.1
Change from FY21 to FY25
millions USD
FY21:
26.5
FY22:
90.6
FY23:
−69.1
FY24:
40.2
FY25:
−113
Change from FY21 to FY25
millions USD
FY21:
53.1
FY22:
0.61
FY23:
13.8
FY24:
29.4
FY25:
175
millions USD
FY21:
−13.8
FY22:
6.79
FY23:
−32.6
FY24:
18.5
FY25:
20.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−96.5
FY22:
−84.6
FY23:
22.5
FY24:
−51.1
FY25:
−41.2

All amounts in millions USD Data source:SEC EDGAR